Director, Clinical Operations at Acadia Pharmaceuticals

Foster City, California, United States

Apply Now

Not SpecifiedCompensation

Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Biopharmaceutical, Rare DiseasesIndustries

Skills

Key technologies and capabilities for this role

Clinical Trial ManagementBudget ManagementResource PlanningGCPICHFDA RegulationsProject ManagementLeadershipCross-functional Collaboration

Questions & Answers

Common questions about this position

What are the main responsibilities of the Director, Clinical Operations role?

The role involves providing leadership to clinical programs, ensuring studies meet goals for timeline, budget, and quality, overseeing clinical operations teams, managing CROs and vendors, and representing Clinical Operations at Product Team meetings.

What company values does Mirum Pharmaceuticals emphasize?

Mirum values care, be real, get it done, and have fun, seriously, seeking collaborative, creative, and experienced professionals.

Is the salary or compensation specified for this position?

This information is not specified in the job description.

What is the work location or remote policy for this role?

This information is not specified in the job description.

What makes a strong candidate for the Director, Clinical Operations position?

Strong candidates should have leadership experience in clinical trial management, strategic oversight of programs, vendor management skills, and the ability to align resources with company goals while embodying Mirum's values.

Acadia Pharmaceuticals

Develops therapies for neurological disorders

About Acadia Pharmaceuticals

Acadia Pharmaceuticals develops therapies for neurological disorders, focusing on conditions like Parkinson's disease, schizophrenia, and Rett syndrome. The company conducts extensive research and clinical trials to create drugs that are safe and effective, seeking approval from regulatory bodies like the FDA before bringing them to market. Acadia differentiates itself by targeting areas with significant unmet medical needs, ensuring that their products address critical health challenges. Their goal is to improve the quality of life for patients suffering from these disorders while also promoting diversity, equity, and inclusion within their operations.

Dallas, TexasHeadquarters

1993Year Founded

$813.4MTotal Funding

ACQUISITIONCompany Stage

Biotechnology, HealthcareIndustries

501-1,000Employees

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

401(k) Company Match

Employee Stock Purchase Plan

Paid Vacation

Paid Holidays

Paid Sick Leave

Paid Parental Leave

Tuition Reimbursement

Risks

Increased competition in CNS drug market may impact Acadia's market share.

Potential clinical trial delays could affect drug approval timelines.

Dependence on partnerships poses risks if collaborations face challenges or dissolve.

Differentiation

Acadia focuses on CNS disorders with unmet medical needs, like Parkinson's and Rett syndrome.

The company has a strong R&D foundation, developing innovative small molecule drugs.

Acadia's strategic partnerships enhance its research capabilities and market reach.

Upsides

Acadia's collaboration with Saniona expands its portfolio with SAN711 for neurological disorders.

Health Canada's approval of Daybue boosts Acadia's presence in the Canadian market.

The rise of personalized medicine aligns with Acadia's targeted therapy approach.

Land your dream remote job 3x faster with AI

Try Jobo Free